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esponsibility of Xi’Abstract Flavonoids are structurally diverse and the most ubiquitous groups of polyphenols distributed
in the various plants, which possess intensive biological activities. In this study, the interaction
mechanisms between four ﬂavonoids containing one glucose unit with similar molecular weight isolated
from the Tibetan medicinal herb Pyrethrum tatsienense, namely, apigenin-7-O-β-D-glucoside(1), luteolin-
7-O-β-D-glucoside(2), quercetin-7-O-β-D-glucoside(3), quercetin-3-O-β-D-glycoside(4), and human
serum albumin(HSA), were investigated by ﬂuorescence, UV–vis absorbance, circular dichroism, and
molecular modeling. The effects of biological metal ions Mg2þ, Zn2þ, and Cu2þ on the binding afﬁnity
between ﬂavonoids and HSA were further examined. Structure–activity relationships of four ﬂavonoids
binding to HSA were discussed in depth and some meaningful conclusions have been drawn by the
experiment data and theoretical simulation. In addition, an interesting phenomenon was observed that the
microenvironment of the binding site I in HSA has hardly changed in the presence of 4 differentiating
from the other three ﬂavonoids on the basis of conformation investigations.
& 2014 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Human serum albumin (HSA), the most abundant protein in blood
serum with a concentration of 0.63 mM, is the major soluble
transport protein in the circulatory system for reversibly binding a
large diverse of metabolites and organic compounds such assity. Production and hosting by Else
1
9358075, þ86 20 36586254.
.cn (A.-Z. Wu),
an Jiaotong University.unesteriﬁed fatty acids, hormones, and metal ions [1]. HSA not
only plays a signiﬁcant role in absorption, distribution, metabolism
and excretion of drug, but also inﬂuences the drug toxicity and
stability during the chemotherapeutic process in the circulatory
systems [2]. It is well known that the functions of various drugs are
strongly affected by the protein–drug interactions in blood plasma.
The deep knowledge of the mechanism of the drug–HSA interac-
tion is of great importance in understanding the process of drug
transportation, the prediction of the free drug concentrations, and
the clinical application. Consequently, the study on the binding of
drug to HSA may provide some useful information of structurevier B.V. All rights reserved.
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Fig. 1 The chemical structures of the four ﬂavonoids.
Differences of ﬂavonoids binding to human serum albumin 393features that determine the therapeutic effect of drug, and has
become an important research ﬁeld in life sciences [3].
Flavonoids are widely distributed in plants and are also present in
considerable amounts in Pyrethrum tatsienense, which could be
regarded as the most representatively secondary metabolites of this
Tibetan medicinal herb in China [4]. Research on ﬂavonoids has
witnessed a remarkable interest during the last decades, due to high
efﬁcacy and low toxicity of these compounds that make them viable
alternatives to conventional medicines [5]. Among therapeutic proper-
ties of ﬂavonoids, we mention antioxidant [6], anti-cancer, anti-AIDS,
anti-inﬂammatory, anti-neoplastic, as well as neuro-protective activities
[7,8]. It can be predicted that a huge number of biochemical signaling
pathways and, therefore, physiological and pathological processes, can
be affected by ﬂavonoids [9]. Thus, the structure–activity relationship of
ﬂavonoids binding to HSA is especially important in further evaluating
the transportation and distribution of ﬂavonoids in blood.
Spectral methods are powerful tools for the study of drug binding to
proteins since they allow nonintrusive measurements of substances in
low concentrations [3]. In this work, four ﬂavonoids (Fig. 1), namely,
apigenin-7-O-β-D-glucoside (1), luteolin-7-O-β-D-glucoside(2), querce-
tin-7-O-β-D-glucoside(3), and quercetin-3-O-β-D-glycoside(4), were
isolated from P. tatsienense by our group [10]. The mechanism and
characteristics of interaction between the above ﬂavonoids (containing
one glucose unit with similar molecular weight) and HSA were ﬁrst
investigated systematically by spectroscopic and molecular modeling
methods. The effects of some metal ions, the number of phenolic
hydroxyl and location of glycosylation in ﬂavonoids on the binding
afﬁnity between the ﬂavonoids and HSA were discussed in depth. We
hope that this study will be helpful for realizing the transportation and
distribution of ﬂavonoids in vivo at the molecular level, which is also in
some degree beneﬁcial to the in-depth understanding of therapeutic
effects of P. tatsienense herb.2. Experimental
2.1. Materials and apparatus
HSA was obtained from Sigma Chemical Company(USA). Four
ﬂavonoids were isolated from P. tatsienense (Bur. et Franch.) Ling.
Their purities were over 98% by normalization of the peak areas
detected by HPLC-UV. Steady-state ﬂuorescence measurements were
carried out through a F2500 spectrophotometer (Hitachi, Japan). UV–
vis and CD measurements were performed with a UV1000 UV–vis
spectrophotometer (Techcomp, China) and Chirascan spectropolari-
meter (Applied Photophysics Ltd., England), respectively.
2.2. Spectroscopic measurement
Four ﬂavonoids were dissolved in ethanol to obtain 1.20 103 M
stock solution, respectively. A Tris–HCl buffer (0.10 M, pH¼7.4)containing 0.10 M NaCl was selected to keep the pH value
constant and to maintain the ionic strength of the solution.
Fluorescence measurements were carried out keeping the concen-
tration of HSA ﬁxed at 4.0 107 M and that of drugs varied from
0 to 2.88 105 M. The excitation wavelength was 280 nm and
the intrinsic ﬂuorescence emission spectra of HSA were recorded at
three different temperatures (25, 31 and 37 1C). Absorption spectra
were recorded at 0.5 nm intervals keeping the concentration of
HSA ﬁxed at 1.0 105 M and that of drugs varied from 0 to
4.0 105 M. CD spectra were recorded at 0.5 nm intervals under
constant nitrogen ﬂush keeping the concentration of HSA ﬁxed at
2.00 106 M and the mole ratio of the drugs to HSA varied from
0:1 to 20:1.
The ﬂuorescence spectra of HSA were also recorded in the
presence of some metal ions, which contained Zn2þ, Mg2þ, and
Cu2þ at 25 1C in the range of 280–600 nm at excitation wavelength
of 280 nm. In the system, the overall concentrations of HSA and
the metal ions were ﬁxed at 6.0 104 M.
The crystal structure of HSA was taken from the Brookhaven
Protein Data Bank (entry codes 1h9z). The potential 3D structure
of HSA was assigned according to the Amber 4.0 force ﬁeld with
Kollman-all-atom charges. The initial structure of all the molecules
was generated by software Sybyl-X1.1. Geometries of the ligands
were optimized using the Tripos force ﬁeld with Gasteiger–Hückel
charges. Surﬂex program was applied to calculate the possible
conformations of the ligand binding to protein in which the lattice
water remained.3. Results and discussion
3.1. Fluorescence quenching of HSA by the four ﬂavonoids
As shown in Fig. 2A, upon addition of the ﬂavonoids into HSA
solution, the ﬂuorescence intensity of HSA at around 347 nm
regularly decreased and the ﬂuorescence intensity decreased tardily
in each titration curve, indicating that the ﬂavonoids could interact
with HSA and that HSA binding site was gradually saturated.
Furthermore, the maximum wavelength of HSA shifted about from
347 to 366 nm after the addition of ﬂavonoids 1, 2 and 3, but the
shift of maximum emission wavelength of HSA after addition of
ﬂavonoid 4 was not observed. A red shift of the emission peak
could be deduced that the Trp-214 residue of HSA was placed in a
more hydrophilic environment [11], namely, the polarity of
microenvironment around Trp-214 of HSA was increased after
addition of ﬂavonoids 1, 2 and 3.
In order to further conﬁrm the possible quenching mechanism of
the four ﬂavonoids binding to HSA, the ﬂuorescence quenching
constants were usually analyzed by the Stern–Volmer equation [12]
and the results are listed in Table 1. The values of Kq decreased
with rising temperature, and were larger than the limiting diffusion
constant Kdiff (2.0 1010 M1 s1) [13], which suggested that the
possible quenching mechanism was a static quenching process
accompanied with the formation of HSA–ﬂavonoid complexes,
while dynamic collision could be negligible.
Because the concentrations of ﬂavonoids were far greater than
those of HSA, the logarithm equation [14,15] used to calculate the
binding constant Ka and the number of binding site n was reasonable
for a static quenching process. The values of Ka and n were obtained
from the intercept and slope of the plots (shown in the inset of
Fig. 2A), and are listed in Table 1, respectively. At 25 1C, Ka was
found as 6.56 105, 7.74 105, 2.85 106, 5.97 105 M1, and n
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Fig. 2 (A) Effects of ﬂavonoid (1) on the ﬂuorescence spectra of HSA in Tris–HCl buffer of pH 7.40 at 25 1C. The inset shows Double-lg plots
for ﬂavonoid (1) at different temperatures. (B) Spectral overlap of HSA ﬂuorescence (a) with the absorption spectra (b) of ﬂavonoid (1).
c(HSA)¼c(ﬂavonoid)¼1.0 105 M.
Table 1 Binding parameters of HSA with the four ﬂavonoids at different temperatures.
Flavonoid T (1C) Ksv ( 105 M1) Kq ( 1013 M1  s1) n Ka (M1) ΔH (kJ/mol) ΔS (J mol/K) ΔG (kJ/mol)
1 25 0.8479 0.8479 1.20 6.56 105 65.06 99.05 33.18
31 0.8477 0.8477 1.17 4.64 105 32.98
37 0.8414 0.8414 1.12 2.81 105 32.34
2 25 0.8569 0.8569 1.22 7.74 105 36.75 10.55 33.59
31 0.8003 0.8003 1.19 5.83 105 33.55
37 0.7577 0.7577 1.17 4.36 105 32.17
3 25 1.3854 1.3854 1.29 2.85 106 54.46 58.94 36.82
31 1.3492 1.3492 1.26 2.00 106 36.68
37 1.3204 1.3204 1.24 1.53 106 36.11
4 25 0.8149 0.8149 1.20 5.97 105 52.11 63.96 32.95
31 0.7775 0.7775 1.17 4.50 105 32.90
37 0.7705 0.7705 1.12 2.64 105 32.17
C.-Z. Lin et al.394was 1.20, 1.22, 1.29, 1.20 for 1-HSA, 2-HSA, 3-HSA and 4-HSA
system, respectively. The values of Ka were proportional to the
number of binding sites n, which conﬁrmed the method used here was
suitable to study the interaction between the four ﬂavonoids and HSA.
n was approximately equal to 1, which indicated that the four
ﬂavonoids could be stored and carried by HSA under physiological
conditions via forming the mole ratio 1:1 complexes. The binding
intensity between the four ﬂavonoids and HSA was 3424144,
which suggested that the binding afﬁnity was affected by the number
of phenolic hydroxyls, and especially the link location of glucose in
the ﬂavonoids. Although ﬂavonoids 3 and 4 had the same number of
phenolic hydroxyls, the latter was more favorable for releasing from
combinative state in blood serum than the former. These results
showed the differences of the four ﬂavonoids in the treatment of
oxidative injury and related diseases. The facts of ΔGo0, ΔHo0 and
ΔSo0 indicated that binding of the four ﬂavonoids to HSA was a
spontaneous inter-molecular reaction. The negative ΔH and ΔS values
were frequently taken as enthalpy driven while entropy was unfavor-
able for it, and the binding process belonged to the exothermic
process. Therefore, hydrogen bond and Van der Waals forces played a
major role in the binding process [16].3.2. Energy transfer from HSA to drugs
According to Förster’s non-radiative energy transfer theory (ERET)
[17], if an acceptor can absorb the emitted ﬂuorescence from a
donor, energy may transfer from the donor to the acceptor. The
overlapping between the HSA emission spectra and the ﬂavonoid
absorption spectra (Fig. 2B) means that the non-radiative energy
transfer occurred obviously between the four ﬂavonoids and HSA.
Thus, the quenching mechanism in the ﬂavonoid–HSA binary
systems was a combination of static quenching and non-radiative
energy transfer (Table 2). Using the FRET, the donor-to-acceptor
distance r was 1.21, 1.26, 1.20 and 1.29 nm for the binding of
ﬂavonoids 1, 2, 3 and 4 with HSA, respectively, which was less
than 8 nm, indicating that the energy transferring from HSA to the
ﬂavonoids occurred with high possibility [18]. The order of
distance r between the ﬂavonoids and Trp-214 residue of HSA
was 3o2o1o4, which was just the opposite to the order of
binding constants Ka. These results showed that the donor-to-
acceptor distance r was related to Ka. In other words, the larger the
binding constants, the smaller r would be in the ﬂavonoid–HSA
system.
Table 2 Energy transfer parameters of binding reaction
between the ﬂavonoids and HSA.
Flavonoid J( 1010 cm3/M) E R0 (nm) r (nm)
1 1.63 0.32 1.12 1.28
2 1.47 0.35 1.10 1.26
3 1.90 0.44 1.15 1.20
4 1.60 0.30 1.12 1.29
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In addition to providing experimentally originated spectroscopic
parameters, we also applied the molecular modeling methodology,
which offers a molecular level explanation to estimate the
participation of speciﬁc chemical groups and their interactions in
ﬂavonoid–HSA complex stabilization. Crystal structure of HSA
shows that HSA is a heart-shaped globular protein consisting of a
single polypeptide chain with 585 amino acid residues, which
contains three repeating similar homologous domains numbered I
(residues 1–195), II (196–383) and III (384–585). Each domain is
composed of two sub-domains (A and B). The principal binding
sites with different speciﬁcities are referred to site I and site II [19],
and located in the hydrophobic cavities of sub-domains IIA (Trp-
214 residue located in sub-domain IIA) and IIIA, respectively.
According to the literature [20,21], site I (warfarin binding pocket)
is regarded as the binding site of four ﬂavonoids during the process
of molecular modeling.
Fig. 3 shows the most possible interaction mode between the
four ﬂavonoids and HSA. The calculated binding Gibbs free
energies ΔG were 43.09, 46.36, 47.26, and 37.22 kJ/mol
for 1-HSA, 2-HSA, 3-HSA, and 4-HSA systems, respectively.
According to the formula ΔG¼RT ln Ka, the order of Ka
obtained from molecular modeling was consistent with ﬂuores-
cence results. The interactions of the four ﬂavonoids with binding
site were dominated by hydrogen bonds observed from Fig. 3.
There were three hydrogen bonds between 1 and Arg-222(1.80 Å),
His-242(2.47 Å), Arg-257(1.87 Å) of HSA, seven hydrogen bonds
between 2 and Lys-199(2.45 Å, 2.68 Å), Trp-214(2.27 Å), His-242
(2.00 Å), Arg-257(2.42 Å), Ala-258(2.32 Å), Ala-291(2.62 Å) of
HSA, eight hydrogen bonds between 3 and Lys-199(2.56 Å), Phe-
211(1.86 Å), Arg-222(2.39 Å, 2.57 Å), His-242(1.96 Å), Arg-257
(2.35 Å, 2.54 Å), Ala-291(1.91 Å) of HSA, and six hydrogen
bonds between 4 and Lys-199(2.18 Å), Arg-222(1.79 Å, 2.01 Å,
2.72 Å), His-242(1.82 Å), Ala-291(2.11 Å) of HSA. These data
indicate that the greater the number of hydrogen bonds is, the
larger the binding constants Ka are for ﬂavonoids 1, 2 and 3. These
results well agree with those of ﬂuorescence studies described
above. It is demonstrated that the formation of hydrogen bond
decreases the hydrophilicity and increases the hydrophobicity to
stabilize the ﬂavonoid–HSA system. Although ﬂavonoids 3 and 4
have the same number of phenolic hydroxyls, Ka of 4 is the
smallest. The reason may be that the link location of glucose is at
the 7 position of A ring in 4 differentiating from the other three
ﬂavonoids.
On the other hand, docking of ﬂavonoids 1, 2 and 3 with HSA
creates a hydrophobic environment near Trp-214 shown in
Fig. 3A–C, which provides a good structural basis to explain the
efﬁcient ﬂuorescence quenching of HSA in the presence of these
three ﬂavonoids. And the B ring of these three ﬂavonoids hasformed effective π–π stacking with indole ring of Trp-214 resulting
in the decrease of electron density of indole ring, which reasonably
explains the blue shift of the maximum peaks in UV and CD
spectra (vide infra)of HSA after addition of ﬂavonoids 1, 2 and 3. It
is important to note that the Trp-214 residue of HSA is far from 4
shown in Fig. 3D, which results in poor ﬂuorescence quenching of
HSA emission in the presence of 4. Thus, the acting forces are
mainly hydrogen bond and Van der Waals forces between the four
ﬂavonoids and HSA, which are in accordance with the results of
ﬂuorescence experiment.
3.4. Conformation investigations
To further estimate whether any conformational changes of HSA
molecules occurred in the binding reaction, UV–vis and CD spectra of
HSA were measured. UV–vis spectra (Fig. 4A) show that the
absorption peaks of HSA at 279 nm had an obvious blue shift toward
short wavelength with the increasing addition of ﬂavonoids 1, 2, and 3,
while the maximum absorption peak of 4 had little shift. The reason
may be that the conjugation around the chromophore Trp-214 of HSA
decreases due to the speciﬁc interaction between ﬂavonoid 1 (2, 3) and
HSA. But the binding of 4 with HSA had little effect on the secondary
structure of HSA, which was in accordance with the results of
ﬂuorescence and CD(vide infra). In addition, the absorption peak of
ﬂavonoids 1, 2 and 3 had almost no longer shifted toward short
wavelengths when the mole ratio of the ﬂavonoid to HSA reached
about 20, which suggests at this point the concentrations of the
ﬂavonoid around HSA are basically saturated.
CD spectra (Fig. 4B) exhibit that the bands intensity of HSA at
208 nm decreased in the presence of ﬂavonoid 1, indicating that the
α-helix contents of HSA decreased. The α-helix contents of HSA
were calculated to be 69.50% in free HSA, 66.76% for 1, 66.74%
for 2, 64.47% for 3, and 66.95% for 4 in bound form at mole ratio
of the ﬂavonoid to HSA 20:1 based on the literature [1]. The
decreasing degree of α-helix contents was 3424144, which was
in accordance with the binding constants Ka. Moreover, the band
intensity at 208 nm in the system of HSA and 1 (2, 3) had a weak
red shift toward long wavelength, suggesting the emergence of a
partial β-turn in 1 (2, 3)–HSA systems except in 4-HSA system
[22], which was consistent with the ﬂuorescence results. A small
decrease of α-helix percentage and no signiﬁcant shift of the peaks
indicated that the three-dimensional structure of HSA had a little
change and HSA was also predominantly α-helix after addition of
the ﬂavonoids [23], which displayed slight unfolding of the
constitutive polypeptides of HSA and increased the exposure of
some hydrophobic regions previously buried [24].
3.5. Effect of co-ions on the interaction of the four ﬂavonoids
with HSA
In plasma, there are some essential metal ions, which may affect
the binding properties of drugs and serum albumins, because many
drugs are good coordination groups of metal ions that can bind to
protein. In this study, the effects of some biological metal ions
Mg2þ, Zn2þ, and Cu2þ on the interaction between the ﬂavonoid
and HSA were investigated at 25 1C(Table 3).
Ka0 of 2 increased while Ka0 of 3 decreased when Cu
2þ, Mg2þ,
and Zn2þ coexisted in HSA solution. The reasons may be that 3
with two pairs of two adjacent hydroxyls in A and B ring can form
the stable chain complexes with Cu2þ, Mg2þ, and Zn2þ, which
cannot effectively bind to HSA due to the large volume of
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C.-Z. Lin et al.396complexes. It was speculated that the metal ions might play an “ion
bridging” role among two adjacent phenolic hydroxyls [25]. But 2
with a pair of two adjacent phenolic hydroxyls in B ring can form
the stable complexes (mole ratio of metal ion to ﬂavonoid is 1:2)
with Cu2þ, Mg2þ, and Zn2þ, which can bind to the hydrophobicsite of HSA due to the hydrophobicity of complexes [26].
Although 4 has a pair of two adjacent hydroxyls, the link location
of glucose is at the 3 position of C ring, which is unfavorable to the
effective formation of complexes because of the steric effect of
glucose. In a word, the presence of biological metal ions may
Table 3 Binding constants and sites of HSA with the
ﬂavonoids and metal ions.
Flavonoid Metal ions n Ka0( 105 M1) Ka0/Ka
1 Cu2þ 1.07 4.33 0.66
Zn2þ 1.03 1.98 0.29
Mg2þ 1.18 13.20 2.01
2 Cu2þ 1.18 11.20 1.45
Zn2þ 1.16 9.83 1.27
Mg2þ 1.31 50.90 6.57
3 Cu2þ 1.10 4.05 0.14
Zn2þ 1.08 4.58 0.16
Mg2þ 1.16 1.54 0.54
4 Cu2þ 1.08 4.69 0.79
Zn2þ 1.21 19.20 3.22
Mg2þ 1.09 5.90 0.99
Differences of ﬂavonoids binding to human serum albumin 397shorten or prolong the storage time of ﬂavonoids in blood plasma
and enhance or weaken its maximum effects, and modulate
ﬂavonoid delivery to cells in vitro and in vivo [27].4. Conclusions
In this work, the interaction of four ﬂavonoids isolated from the
Tibetan medicinal herb P. tatsienense with HSA has been
investigated by several spectroscopic techniques and molecular
modeling. The ﬂuorescence results showed that the intrinsic
ﬂuorescence of HSA was quenched through static quenching and
non-radiative energy transfer. The binding afﬁnity of ﬂavonoids to
HSA was 3424144, which was in agreement with the result of
molecular modeling. The results of CD and UV–vis spectra
showed that the formation of ﬂavonoid–HSA complexes induced
changes in different degrees in the protein secondary structure.
The above studies have shown that the following relationship
may exist between the structure and binding interaction of the four
ﬂavonoids with HSA: (1) the increase of phenolic hydroxyls
among ﬂavonoids is favorable for the drug binding to HSA,
(2) the link location of glucose in ﬂavonoids takes a more effect
on the binding afﬁnity than the number of phenolic hydroxyls, (3)
the location of glucose in ﬂavonoids has a signiﬁcant effect on the
microenvironment of binding site in HSA, and (4) ﬂavonoid with
two pairs of two adjacent phenolic hydroxyls in A and B ring
cannot effectively bind to HSA when some metal ions coexist in
HSA due to the formation of chain complexes. This work provides
important structure–activity data for ﬂavonoids binding to HSA,
which serves as valuable clues for understanding the pharmacody-
namic response and therapeutic effects of ﬂavonoids and Tibetan
medical herb P. tatsienense.
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